Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2011-3-10
pubmed:abstractText
To assess the efficiency of IIb/IIIa platelet receptor inhibition by abciximab in the prevention of silent embolism during digital subtraction angiography.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1421-9786
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 S. Karger AG, Basel.
pubmed:issnType
Electronic
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
353-7
pubmed:meshHeading
pubmed-meshheading:21212667-Angiography, Digital Subtraction, pubmed-meshheading:21212667-Antibodies, Monoclonal, pubmed-meshheading:21212667-Brain Ischemia, pubmed-meshheading:21212667-Cerebral Angiography, pubmed-meshheading:21212667-Diffusion Magnetic Resonance Imaging, pubmed-meshheading:21212667-Double-Blind Method, pubmed-meshheading:21212667-Female, pubmed-meshheading:21212667-Germany, pubmed-meshheading:21212667-Humans, pubmed-meshheading:21212667-Immunoglobulin Fab Fragments, pubmed-meshheading:21212667-Intracranial Embolism, pubmed-meshheading:21212667-Male, pubmed-meshheading:21212667-Middle Aged, pubmed-meshheading:21212667-Placebo Effect, pubmed-meshheading:21212667-Platelet Aggregation Inhibitors, pubmed-meshheading:21212667-Platelet Glycoprotein GPIIb-IIIa Complex, pubmed-meshheading:21212667-Prospective Studies, pubmed-meshheading:21212667-Risk Factors, pubmed-meshheading:21212667-Treatment Failure
pubmed:year
2011
pubmed:articleTitle
Abciximab does not prevent ischemic lesions related to cerebral angiography: a randomized placebo-controlled trial.
pubmed:affiliation
Department of Neuroradiology, Medical Faculty Mannheim, University of Heidelberg, Germany. caro.brockmann@gmx.de
pubmed:publicationType
Journal Article, Randomized Controlled Trial